GSK announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults in the EU with uncontrolled COPD characterised by raised blood eosinophils ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results